(19)

(11)

EP 2 836 071 A1

(12)

(43) Date of publication: 18.02.2015 Bulletin 2015/08 (21) Application number: 13710875.9 (22) Date of filing: 21.03.2013

(51) International Patent Classification (IPC):  A01N 37/12(2006.01) A61K 9/107(2006.01) A61K 31/695(2006.01) A01P 7/02(2006.01) A01N 25/28(2006.01) A01N 55/10(2006.01) A61K 9/127(2006.01) A61K 35/06(2006.01) A01N 25/04(2006.01) (86) International application number: PCT/EP2013/055966 (87) International publication number: WO 2013/139927 (26.09.2013 Gazette 2013/39)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 22.03.2012 BE 201200201 (71) Applicant: Omega Pharma Innovation and Development NV 9810 Nazareth (BE)	(72) Inventor: DUHOT, Pierre-Yves B-7500 Tournai (BE) (74) Representative: Brantsandpatents bvba  Pauline Van Pottelsberghelaan 24 9051 Ghent 9051 Ghent (BE)